ImmunotEGG
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
About ImmunotEGG
We develop fluorescently labeled antibodies for the diagnostics and life science research industries. Our new low production cost technology is based on the novel combination of fluorescent quantum dot nanoparticles and hen antibodies purified from egg yolk, this competitive advantage will allow antibody technology to colonize the diagnostics industry!
ImmunotEGG Headquarter Location
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.